Getting your Trinity Audio player ready...
Key Pharmaceuticals Inc. shareholders approved a takeover by Schering-Plough Corp. Key shareholders will exchange each share for .27 shares of Schering-Plough, a swap worth about $575 million.
Key Pharmaceuticals Inc. shareholders approved a takeover by Schering-Plough Corp. Key shareholders will exchange each share for .27 shares of Schering-Plough, a swap worth about $575 million.